Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention

Koelmeyer, L. A., Gaitatzis, K., Dietrich, M. S., Shah, C. S., Boyages, J., McLaughlin, S. A., Taback, B., Stolldorf, D. P., Elder, E., Hughes, T. M., French, J. R., Ngui, N., Hsu, J. M., Moore, A., & Ridner, S. H. (2022). Risk factors for breast cancer–related lymphedema in patients undergoing 3 years of prospective surveillance with intervention. Cancer, 128(18), 3408–3415. Portico. https://doi.org/10.1002/cncr.34377
Authors:
Louise A Koelmeyer
Katrina Gaitatzis
Mary S Dietrich
Chirag S Shah
John Boyages
Sarah A McLaughlin
Bret Taback
Deonni P Stolldorf
Elisabeth Elder
T Michael Hughes
James R French
Nicholas Ngui
Jeremy M Hsu
Andrew Moore
Sheila H Ridner
Affiliated Authors:
Bret Taback
Columbia Affiliation:
Subjects:
Breast Cancer Lymphedema (MeSH)
Breast Neoplasms (MeSH)
Lymphedema (MeSH)
Author Keywords:
bioimpedance spectroscopy
breast cancer
intervention
lymphedema
prospective surveillance
elink
Publication Type:
Article
Unique ID:
10.1002/cncr.34377
PMID:
35797441
DOI:
10.1002/cncr.34377
Journal:
Cancer
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: